SCHEMBL26923826

SCHEMBL26923826

CC[C@H](CN)c1cccc(CC(C)C)c1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NOS3 P29474 1/20 0.42
▸ NOS1 P29475 1/20 0.42
▸ NOS2 P35228 1/20 0.42
▸ PNMT P11086 1/20 0.39
▸ TAAR1 Q96RJ0 7/20 0.37
▸ SLC6A2 P23975 2/20 0.36
▸ MAOA P21397 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ SLC6A3 Q01959 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36
▸ CYP2A6 P11509 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ GABRA1 P14867 1/20 0.35
▸ GABRB2 P47870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26923481 1.00 NOS3 (0.42) NOS3NOS1NOS2PNMTTAAR1
SCHEMBL26923483 1.00 NOS3 (0.42) NOS3NOS1NOS2PNMTTAAR1
SCHEMBL23750142 0.81 GABBR2 (0.42) NOS3NOS1NOS2TAAR1HTR2A
SCHEMBL23750143 0.79 GABBR2 (0.43) NOS3NOS1NOS2HTR2AGABRA1
SCHEMBL23750228 0.79 GABBR2 (0.43) NOS3NOS1NOS2HTR2AGABRA1
SCHEMBL26922835 0.79 TAAR1 (0.41) NOS3NOS1NOS2TAAR1SLC6A2
SCHEMBL26922372 0.79 TAAR1 (0.41) NOS3NOS1NOS2TAAR1SLC6A2
SCHEMBL26922368 0.79 TAAR1 (0.41) NOS3NOS1NOS2TAAR1SLC6A2
SCHEMBL13508600 0.77 PNMT (0.45) NOS3NOS1NOS2PNMT
SCHEMBL11076430 0.77 NOS3 (0.43) NOS3NOS1NOS2TAAR1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4316504-A2 COMPOUNDS Spero Therapeutics, Inc. (US) 2024-02-07 — — EP disclosed
EP-3810633-B1 COMPOUNDS SPERO THERAPEUTICS INC (US) 2023-12-13 — — EP disclosed
Send feedback